General Questions
All organisations serving Low- and Middle-Income Countries (LMICs), as defined by the World Bank.
All listed products have certified WHO-PQ, SRA, and/or IDA Quality Assured. For more information on IDA’s quality assurance mechanisms, please see IDA Foundation’s Commitment to Quality Assurance.
Medications for cancer, diabetes, and cardiovascular diseases are currently available on the platform. Additionally, diagnostics and consumables for cancer and diabetes are partially accessible, with respiratory treatments and cardiovascular diagnostics expected to be live by the end of Q3 2024. Follow NCDconnect on LinkedIn for the most up-to-date information.
Not yet; but it’s coming! We are developing a knowledge library with information such as expertise and recommendations on screening equipment, regimens, treatment, regulations, registrations, procurement processes, etc. If you have specific requests for platform knowledge, please email us at: ncd@idafoundation.org.
Are you a buyer and looking for more information?
Are you a supplier and looking for more information?